The University of Chicago Header Logo

Connection

Richard A. Larson to CD52 Antigen

Back to Details
This is a "connection" page, showing publications Richard A. Larson has written about CD52 Antigen.
Richard A. Larson
Connection Strength
0.091
CD52 Antigen
  1. Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901. Leuk Lymphoma. 2009 Oct; 50(10):1589-96.
    View in: PubMed
    Score: 0.091
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.